The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum

Neuropharmacology

Volumn 48, Issue 3, 2005, Pages 391-397

  Koike, Kaori ^a   Hashimoto, Kenji ^a   Fukami, Goro ^a   Okamura, Naoe ^a   Zhang, Lin ^a   Ohgake, Shintaro ^a   Koizumi, Hiroki ^a   Matsuzawa, Daisuke ^a   Kawamura, Noriyuki ^b   Shimizu, Eiji ^a   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Dopamine; FK506 (tacrolimus); Methamphetamine; Neurotoxicity; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; DOPAMINE TRANSPORTER; IMMUNOPHILIN; METHAMPHETAMINE; TACROLIMUS; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; ATTENUATION; BODY TEMPERATURE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG INHIBITION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUSE; MOUSE STRAIN; NERVE CELL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 20844463759     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2004.10.015     Document Type: Article

References (28)

1. D.S. Albers, and P.K. Sonsalla Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents J. Pharmacol. Exp. Ther. 275 1995 1104 1114
2. S.F. Ali, and Y. Itzhak Effects of 7-nitroindazole, an NOS inhibitor on methamphetamine-induced dopaminergic and serotonergic neurotoxicity in mice Ann. N.Y. Acad. Sci. 844 1998 122 130
3. S.F. Ali, G.D. Newport, and W. Slikker Jr. Methamphetamine-induced dopaminergic toxicity in mice. Role of environmental temperature and pharmacological agents Ann. N.Y. Acad. Sci. 801 1996 187 198
4. J.L. Cadet, S. Jayanthi, and X. Deng Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis FASEB J. 17 2003 1775 1788
5. G.D. Cappon, C. Pu, and C.V. Vorhees Time-course of methamphetamine- induced neurotoxicity in rat caudate-putamen after single-dose treatment Brain Res. 863 2000 106 111
6. C. Davidson, A.J. Gow, T.H. Lee, and E.H. Ellinwood Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment Brain Res. Brain Res. Rev. 36 2001 1 22
7. T.M. Dawson, J.P. Steiner, V.L. Dawson, J.L. Dinerman, G.R. Uhl, and S.H. Snyder Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity Proc. Natl. Acad. Sci. U.S.A. 90 1993 9808 9812
8. T.M. Dawson, J.P. Steiner, W.E. Lyons, M. Fotuhi, M. Blue, and S.H. Snyder The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin Neuroscience 62 1994 569 580
9. V.L. Dawson, T.M. Dawson, E.D. London, D.S. Bredt, and S.H. Snyder Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures Proc. Natl. Acad. Sci. U.S.A. 88 1991 6368 6371
10. V.L. Dawson, V.M. Kizushi, P.L. Huang, S.H. Snyder, and T.M. Dawson Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice J. Neurosci. 16 1996 2479 2487
11. Y. Furuichi, K. Katsuta, M. Maeda, N. Ueyama, A. Moriguchi, N. Matsuoka, T. Goto, and T. Yanagihara Neuroprotective action of tacrolimus (FK506) in focal and global cerebral ischemia in rodents: dose dependency, therapeutic time window and long-term efficacy Brain Res. 965 2003 137 145
12. B.G. Gold, V. Densmore, W. Shou, M.M. Matzuk, and H.S. Gordon Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506 J. Pharmacol. Exp. Ther. 289 1999 1202 1210
13. X. Guo, V.L. Dawson, and T.M. Dawson Neuroimmunophilin ligands exert neuroregeneration and neuroprotection in midbrain dopaminergic neurons Eur. J. Neurosci. 13 2001 1683 1693
14. X. Guo, J.F. Dillman 3rd, V.L. Dawson, and T.M. Dawson Neuroimmunophilins: novel neuroprotective and neuroregenerative targets Ann. Neurol. 50 2001 6 16
15. S.Z. Imam, J. el-Yazal, G.D. Newport, Y. Itzhak, J.L. Cadet, W. Slikker Jr., and S.F. Ali Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts Ann. N.Y. Acad. Sci. 939 2001 366 380
16. M.W. Jakowec, K. Nixon, E. Hogg, T. McNeill, and G.M. Petzinger Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway J. Neurosci. Res. 76 2004 539 750
17. T. Kita, S. Paku, M. Takahashi, K. Kubo, G.C. Wagner, and T. Nakashima Methamphetamine-induced neurotoxicity in BALB/c, DBA/2N and C57BL/6N mice Neuropharmacology 37 1998 1177 1184
18. Y. Kitamura, Y. Itano, T. Kubo, and Y. Nomura Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice J. Neuroimmunol. 50 1994 221 224
19. A. Klettner, and T. Herdegen FK506 and its analogs - therapeutic potential for neurological disorders Curr. Drug Targets CNS Neurol. Disord. 2 2003 153 162
20. J.F. Nash, and B.K. Yamamoto Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine Brain Res. 581 1992 237 243
21. T. Ohmori, T. Abekawa, and T. Koyama The role of glutamate in behavioral and neurotoxic effects of methamphetamine Neurochem. Int. 29 1996 301 307
22. Y. Sekine, M. Iyo, Y. Ouchi, T. Matsunaga, H. Tsukada, H. Okada, E. Yoshikawa, M. Futatsubashi, N. Takei, and N. Mori Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET Am. J. Psychiatry 158 2001 1206 1214
23. J. Sharkey, and S.P. Butcher Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia Nature 371 1994 336 339
24. S.H. Snyder, D.M. Sabatini, M.M. Lai, J.P. Steiner, G.S. Hamilton, and P.D. Suzdak Neural actions of immunophilin ligands Trends Pharmacol. Sci. 19 1998 21 26
25. P.K. Sonsalla, D.E. Riordan, and R.E. Heikkila Competitive and noncompetitive antagonists at N-methyl-d-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice J. Pharmacol. Exp. Ther. 256 1991 506 512
26. H. Terada, M. Matsushita, Y.F. Lu, T. Shirai, S.T. Li, K. Tomizawa, A. Moriwaki, S. Nishio, I. Date, T. Ohmoto, and H. Matsui Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide J. Neurochem. 87 2003 1145 1151
27. T. Tsukamoto, M. Iyo, K. Tani, Y. Sekine, K. Hashimoto, Y. Ohashi, K. Suzuki, Y. Iwata, and N. Mori The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats Psychopharmacology (Berl) 158 2001 107 113
28. N.D. Volkow, L. Chang, G.J. Wang, J.S. Fowler, M. Leonido-Yee, D. Franceschi, M.J. Sedler, S.J. Gatley, R. Hitzemann, Y.S. Ding, J. Logan, C. Wong, and E.N. Miller Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers Am. J. Psychiatry 158 2001 377 382